These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3434820)

  • 21. [Analytical reactions of mefenamic and flufenamic acids].
    Devaux G; Mesnard P; Brisson AM
    Ann Pharm Fr; 1969 Mar; 27(3):239-48. PubMed ID: 5400246
    [No Abstract]   [Full Text] [Related]  

  • 22. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
    Linari G; Spanò R
    Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990
    [No Abstract]   [Full Text] [Related]  

  • 24. Application of photodiode array UV detection in the development of stability-indicating LC methods: determination of mefenamic acid.
    Maron N; Wright G
    J Pharm Biomed Anal; 1990; 8(1):101-5. PubMed ID: 2102261
    [No Abstract]   [Full Text] [Related]  

  • 25. Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?
    Lee EH; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):4013-22. PubMed ID: 20589947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-complement activity of some non-steroid anti-inflammatory drugs in vitro and in vivo (indomethacin, phenylbutazone, aspirin, mefenamic acid and flufenamic acid)].
    Di Perri T; Auteri A
    Reumatismo; 1972; 24(2):160-3. PubMed ID: 4681341
    [No Abstract]   [Full Text] [Related]  

  • 27. Ion-pair partition chromatography of mefenamic acid with tetraalkylammonium cations: development of analytical method from extraction data.
    Adams WM
    J Assoc Off Anal Chem; 1983 Sep; 66(5):1178-81. PubMed ID: 6630131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of indirect atomic absorption analysis of drugs by forming complexes. II. Determination of flufenamic acid in perfusion experiment using the rat and pharmaceutical preparations.
    Minamikawa T; Sakai K; Hashitani N; Fukushima E; Yamagishi N
    Chem Pharm Bull (Tokyo); 1973 Aug; 21(8):1632-40. PubMed ID: 4756817
    [No Abstract]   [Full Text] [Related]  

  • 29. Simultaneous determination of non-steroidal anti-inflammatory drugs in river water samples by liquid chromatography-tandem mass spectrometry using molecularly imprinted polymers as a pretreatment column.
    Hoshina K; Horiyama S; Matsunaga H; Haginaka J
    J Pharm Biomed Anal; 2011 Jul; 55(5):916-22. PubMed ID: 21470812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.
    Jabeen S; Dines TJ; Leharne SA; Chowdhry BZ
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Oct; 96():972-85. PubMed ID: 22954807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of flufenamic acid, its derivatives and analogous compounds].
    Dell HD; Kamp R
    Arch Pharm Ber Dtsch Pharm Ges; 1970 Oct; 303(10):785-91. PubMed ID: 5275816
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous spectrophotometric determination of mefenamic acid and paracetamol in a pharmaceutical preparation using ratio spectra derivative spectrophotometry and chemometric methods.
    Dinç E; Yücesoy C; Onur F
    J Pharm Biomed Anal; 2002 Jun; 28(6):1091-100. PubMed ID: 12049974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of two fenamates in plasma by high-performance liquid chromatography.
    Lin CK; Lee CS; Perrin JH
    J Pharm Sci; 1980 Jan; 69(1):95-7. PubMed ID: 7354456
    [No Abstract]   [Full Text] [Related]  

  • 34. Cricular dichroism studies of drug-protein complexes.
    Chignell CF
    Life Sci; 1968 Nov; 7(22):1181-6. PubMed ID: 5716617
    [No Abstract]   [Full Text] [Related]  

  • 35. The place of mefenamic acid in the treatment of rheumatoid arthritis.
    Mavrikakis ME; Madkour MM; Buchanan WW
    Scott Med J; 1978 Apr; 23(2):189-90. PubMed ID: 306128
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.
    Ottolia M; Toro L
    Biophys J; 1994 Dec; 67(6):2272-9. PubMed ID: 7535111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin.
    Mason RM; Barnardo DE; Fox WR; Weatherall M
    Ann Rheum Dis; 1967 Sep; 26(5):373-88. PubMed ID: 6039589
    [No Abstract]   [Full Text] [Related]  

  • 38. HPLC determination of etofenamate and flufenamic acid in biological material.
    Dannhardt G; Laufer S; Lehr M
    Clin Chem; 1988 Dec; 34(12):2580-1. PubMed ID: 3197312
    [No Abstract]   [Full Text] [Related]  

  • 39. Complexes of Fe(III) ions with mefenamic acid.
    Bojarowicz H; Kokot Z; Surdykowski A
    J Pharm Biomed Anal; 1996 Dec; 15(3):339-42. PubMed ID: 8951693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary dysmenorrhoea and flufenamates.
    N Z Med J; 1978 May; 87(611):322. PubMed ID: 276706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.